The chronic pain community may have lost one of its strongest advocates based on nothing more than a tweet and complaint filed by Julie Roy of upstate New York, who’s not even a patient of Dr. Kline. Like some storyline out of a WWII movie, the informant rats on an innocent man to the Gestapo, based on some misplaced idealogic motivation that she is doing something good. The victim loses their ability to care for the sick and provide a living for himself, all this in a democracy where innocence is presumed until proven guilty. Such is the nature of opioid hysteria in this country today.
Policymakers in Ontario are correcting a rule that should have never been instituted in the first place. They realized that forced tapering of pain medications is “arbitrary and inappropriate,” and decreed that physicians will no longer be required to wean patients off of prescription opioids.
Federal prosecutors in 2018 wanted to criminally charge Walmart over the company’s opioid sales, but top Trump administration law-enforcement officials killed that effort, a bombshell report says. The efforts to prosecute, represent yet another example of Justice Officials wanting to hold pharmacy retailers to account after changing rules, definitions and interpretations of existing regulations and standards. Redefining what constitutes excess in prescribing and dispensing opioids began around 2010 and did not become official until the publication of the 2016 prescribing guidelines from the CDC. Even then, this standard is incomplete and ambiguous, addressing prescribing standards only for opioid-naive patients and primary care providers.
With Ohio and Kentucky still entrenched in the addiction crisis, what should be done next? Experts, local leaders give their takes. …
Mallinckrodt announced Tuesday that the proposed deal will resolve all opioid-related claims against the company and its subsidiaries if it moves forward. Plaintiffs would receive payments over an eight-year period to cover the costs of opioid-addition treatments and other needs.
The DEA has reduced the supply of opioids, to the point where it creates a shortage of injectable drugs for use in critical care hospitals. They do so believing that it will somehow reduce opioid overdose deaths, addiction and diversion. Such actions do nothing more than punish innocent people for what happens on the street and places everyone at risk at a time when they should be able to rely on critical care at their local hospital.
There’s nothing remotely funny about this persistent incompetence which has caused both suffering and death by adhering to their idiotic plan of combating addiction by strangling the supply of prescription painkillers. It’s now the world’s worst-kept secret that the plan has failed on more levels than Super M ario Brothers. But there’s always room for “improvement.” So let’s hear it for PROP, the CDC, and the DEA for helping provide us with two epidemics of two really dangerous drugs – neither of which is medically useful (1) – in place of a far less dangerous class of medicinally necessary medicines.
Ohio data continues to show a reduction in prescribed opioids through tight control over supplies and prescribing. But these gains are not are translating to a reduction in drug overdose deaths as was initially stated. For the 1st two months of 2020, suicides are up 40% over 2019, showing no slow down in drug-related overdose deaths.
The Trump administration rolled out its proposed Fiscal Year (FY) 2021 National Drug Control Budget Tuesday, and it’s pretty much more of the same — $35.7 billion more, to be precise.